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ABSTRACT 
Physalis minima a medicinally important plant of the family Solanaceae has been screened for its anticancer activity. The 
results of preliminary phytochemical screening of the leaf extract revealed the presence of flavonoids, alkaloids, tannins, 
saponins, steroids, cardiac glycosides, reducing sugars and terpenoids. Determination of total phenolic contents revealed 
that methanolic extract showed 78.3 mg/g of phenolic compounds.  Evaluation of total flavonoid content showed 61.3 mg/g 
of flavonoid. It was found that the % viability of HeLa cell line & Hep
2 
cell line are 80% & 71.8% respectively. The 
percentage of growth inhibition of methanolic extract in SRB assay was found to be increase with increasing concentration 
against both HeLa and Hep
2
cell lines (68 and 58% respectively). The methanolic extract showed the strongest growth 
inhibitory effect on both HeLa and Hep
2 
cell lines (85 and 73% respectively) in MTT assay. Flavonoids have been isolated 
and purified from the methanolic leaf extract.  
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INTRODUCTION 
Cancer is a leading cause among various diseases attributed to mortality in humans all over the world [1]. Plants have 
been a prime source of highly effective conventional drugs for the treatment of many forms of cancer. They have long 
history used in the treatment of cancer. Active constitutes of Catharanthus roseus, Angelica gigas, Podophyllum peltatum, 
Taxus brevifolia, Podophyllum emodii, Ocrosia elliptica, and Campototheca acuminata have been used in the treatment of 
advanced stages of various malignancies [2]. Many medicinal plants reported to have anti-cancer as well as anti-
inflammatory activity in the Ayurvedic system of medicine. Hartwell, in his review of plants used against cancer, lists more 
than 3000 plant species that have reportedly been used in the treatment of cancer [3]. It is significant that over 60% of 
currently used anti-cancer agents are derived in one way or another from natural sources, including plants, marine 
organisms and micro-organisms. Plant-derived compounds have played an important role in the development of several 
clinically useful anti-cancer agents. These include vinblastine, vincristine, the  camptothecin derivatives, topotecan and 
irinotecan, etoposide, derived from epipodophyllotoxin, and paclitaxel.  
Physalis minima belonging to the family of Solanaceae are an annual herb having 0.5-1.5 m height with a very 
delicate purple-tinged stem and leaves.  It is found throughout India and is reported as one of the important medicinal 
plants in Indian traditional system of medicines. It is found on the bunds of the fields, wastelands, around the houses, on 
roadsides, etc. where the soil is porous and rich in organic matter. Leaves are petiolate, ovate to cordate. Flowers are 
pedicellate, hermaphrodite, complete, solitary and companulate. The flowering and fruiting season starts from March-April 
and continues up to the end of November. Fruits are a berry, enclosed within the enlarged, ribbed, reticulately veined 
calyx, which is 4.1 cm long and 2.5 cm broad [4-6]. It has been used traditionally in the treatment of various ailments and it 
contains steroidal lactones, steroids, alkaloids and flavanoids compounds in various parts. The plant is appetizing, diuretic, 
laxative and useful in inflammations, antigonorrhoeic, enlargement of the spleen and abdominal troubles [7]. Fruits and 
flowers are used in stomach pain and in constipation, Herb paste is applied in ear disorders [8]. Ripen fruits are used in 
gastric trouble [9]. The decoction of the whole plant is consumed by the Malay community in Malaysia as a remedy for 
cancer [10]. It is used in treatment of asthma, bronchitis, inflammation, enlargement of spleen, urinary disorder, abdominal 
troubles and headache. The roots are used as vermifuge and febrifuge and treatment of diabetes [11, 12]. Further, 
pharmacological and phytochemical exploration is required for systematic investigation of this plant.  The aim of the 
present study was to evaluate anticancer activity of the leaf extracts.   
MATERIALS AND METHODS 
Chemicals     
 Methanol, Fehling’s solution (A and B), Ammonia, Aluminium chloride, Ferric chloride, Acetic acid, Mayer’s 
reagent, Draggendorff’s reagent, Folin-Ciocalteu reagent, Sodium carbonate, Gallic acid, Sodium nitrite, Sodium 
hydroxide, were purchased from M/S Sisco Research laboratories, Mumbai, India. Quercetin, Trypan Blue, 
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Sulphorodamine B, Trichloroacetic acid, MTT [3-(4, 5-Dimethylthiazol-2-yl)-2, 5-Diphenyltetrazolium Bromide], Dimethyl 
sulfoxide were purchased from Sigma (St. Louis, USA). All chemicals and solvents used were of analytical grade. 
Plant material collection and extraction 
The leaves of Physalis minima for the present investigation was collected from different areas in Karnataka such as 
Bangalore, Chikmagalur, Karwar, Mysore, Shimoga, Tumkur and Uttarakannada district. The collected materials were 
washed thoroughly in water, shade dried for a week and ground to a coarse powder in electric grinder. Hundred grams of 
powder was extracted in soxhlet apparatus successively with solvents of increasing polarity viz., hexane, ethyl acetate, 
acetone and methanol separately. The soxhelation process was carried out until the solvent was found to be colorless.  
The extracts were concentrated using a rotary flash evaporator. The aqueous extract was prepared by homogenizing the 
powder in distilled water for 24 hrs in a shaker, the mixture was filtered and the filtrate was lyophilized.  
Phytochemical analysis  
The prepated extracts were studied for their phytoconstituents such as flavonoids, alkaloids, terpenoids, tannins, 
saponins, reducing sugars, steroids, anthraquinones and cadiac glycosides.  Phytochemical screening was perfomed 
using standard procedures [13].   
Determination of Total phenolics  
The total phenolic content of the methanolic extract was evaluated by using the method described by Singleton and Rossi 
[14] with slight modifications. Briefly, 1 mL of sample was mixed with 1 ml of Folin-Ciocalteu reagent. After 3 min, 1 mL of 
saturated Na2CO3 solution was added to the mixture followed by the addition of 7 ml of distilled water. The mixture was 
kept in the dark for 90 min, after which the absorbance was read at 725 nm. The total phenol contents were determined 
using a standard curve prepared with gallic acid. The results were mean ± standard deviations and expressed as milligram 
of gallic acid equivalent/g of extract.  
Determination of Total flavonoids 
The total flavonoid content of methanolic extract was determined by the method described by Zhishen et al [15]. Briefly, 
250 μl of sample was mixed with 1 ml of distilled water and 150 μl of sodium nitrite solution. After 6 minutes, 75 μl of 
aluminium chloride solution was added and then the mixture was allowed to stand for a further 5 minutes. Then, 1 ml of 
NaOH solution was added. The mixture was made up to 2.5 ml with distilled water. The absorbance was measured at 
510 nm. Total flavonoid content was expressed as mg quercetin equivalent (QE)/g dried extract. The values expressed 
are the average of three measurements.  
Anticancer activity 
Cell lines  
HeLa and Hep
2 
Cell lines were collected from National Centre for Cell Science, University of Pune Campus, Pune for 
anticancer activity study. The percentage viability of the cell line was carried out by using Trypan blue dye exclusion 
method. Antitumor potentials of prepared extracts against HeLa and Hep
2
 cell lines were investigated using SRB and MTT 
assay.  
Trypan blue dye exclusion assay 
The percentage of viability of cell lines was determined by using trypan blue dye exclusion technique [16, 17]. Briefly, 
50µL of cell suspension was mixed with an equal volume of trypan blue. The mixture was transferred to a hemocytometer 
and counted the live cell as clear form and dead cell as blue from under inverted microscope. The percent viability has 
been calculated by using the following equation:  
% viability = (live cell count/total cell count) X100 
Sulphorodamine B assay 
Antitumor potentials of the extracts were determined according to the method described by Skehan et al and Masters [18, 
19]. Briefly, the monolayer cell culture was trypsinized and the cell count was adjusted to 0.5-1.0 x 105 cells/ml. To each 
well of the 96 well microtitre plate, 0.1ml of the diluted cell suspension (approximately 10,000 cells) was added. After 24 
hours, the supernatant was flicked off, washed once and 100 μl of different extracts with different concentrations were 
added to the cells in microtitre plates. The plates were then incubated at 37
o
C for 72 hours in 5% CO2 incubator. After 72 
hours, 25 μl of 50% trichloroacetic acid was added to the wells gently and were incubated at 4
o
C for one hour. The plates 
were flicked and washed with tap water and then air-dried. The air-dried plates were stained with 100μl SRB and kept for 
30 minutes at room temperature. The unbound dye was removed by rapidly washing with 1% acetic acid. 100 μl of 10mM 
Tris base was then added to the wells and the absorbance was measured at 540nm. The percentage growth inhibition 
was calculated using following formula: 
% cell inhibition= 100-[(At-Ab)/ (Ac-Ab)] X 100 
Where, At= Absorbance value of test compound, Ab= Absorbance value of blank and Ac=Absorbance value of control 
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MTT assay 
Cytotoxicity of the extracts was assessed by standard protocol [20, 21]. In brief,  the cells were seeded into 4 
wells of a 96-well micro titer plate at 2 X 10
4 
cells per well with 100 µl growth medium and then incubated for 24 hrs. at 
37ºC under 5% CO2.  Then, the medium was removed and fresh growth medium containing prepared extracts at different 
concentrations (40, 80, 120, 160 and 200µg/ml) were added separately and incubated at 37 
0
C for 3 days. The medium 
was removed after incubation and 0.1 mg/ml MTT reagent was added and incubated for 5 hrs. at 37ºC.  Then, the MTT 
reagent was removed and 100 µl of DMSO was added to each well.  The absorbance was read at 516 nm.    The inhibition 
of cell growth was calculated using the following formula:  
[(Ac–As)/Ac]×100 
Where Ac is the absorbance of the control and As is the absorbance of the sample. The results were mean ± standard 
deviations. 
Isolation and partial purification of anticancer compounds 
 The compounds were isolated and purified from the methanolic extract by using different chromatographic 
techniques (TLC, Column chromatography and HPLC).  The compounds were characterized using standard techniques 
(UV-visible, LC-MS). 
Thin layer chromatography (TLC) 
Phytoconstituents of the methonolic leaf extract of Physalis minima were separated using thin layer 
chromatography (TLC).  Aliquots of 200µg of extracts were loaded on TLC plates (TLC F254; Merck, India). Different 
solvent systems of varying polarity were used to separate anticancer compounds. The solvent system acetone and ethyl 
acetate (60:40 v/v) showed the best separation.  The developed plates were air dried and exposed to iodine to locate the 
spots.  
Colum chromatography 
The column was packed in the form of slurry of silica gel (60-120 mesh,) and gradient elution was carried out by 
using different combinations of solvents.  The respective fractions were collected and concentrated by flash evaporation. 
Similar fractions were pooled after TLC analysis then assayed for anticancer activity. 
HPLC  
The isolated bioactive compounds were tested for its purity using HPLC [LC-solution, ShimadzuTM, MAO 1527, USA with 
LC-UV-100 UV detector, A CAPCELL(C-18) Column RP (18.5μm, 250 4.0 mm), type MG 520μm, number AKAD/05245]. 
The mobile phase consisted of solvent mixtures (Acetonitrile: Water- 70:30) with a flow rate of 1.0ml/min. The injection 
volume was 20 μl, and UV detection was effected at 254nm.  
Identification of bioactive compounds by analytical methods 
UV-visible spectrometry 
The UV-visible spectrum of the isolated compound in HPLC grade methanol was recorded by using Shimadzu 
160A UV- visible spectrophotometer.  
Liquid Chromatography-Mass Spectrometry (LC-MS)  
The system consisted of a Hitachi L-6000 pump (Hitachi, Tokyo, Japan), a Rheodyne model 7125 injector with a 
25 mL loop, and a 4.6 i.d. 325.0 mm Devosil C30 UG-5 column (Nomura Chemical, Seto, Japan). LC was performed using 
an aqueous solution containing methanol and acetonitril as the mobile phase at a flow rate of 1 mL/min. The spectra were 
recorded on a TSQ 700 triple-quadrupole mass spectrometer (Finnigan MAT, San Jose, CA) equipped with an ESI source 
with an ICIS II data system in the positive ion mode using a spray voltage of 9.8 kV, at a source temperature of 90°C. The 
flow rate was 10 µL/min.  
Statistical analysis 
 All experiments were carried out in triplicates.  Data were expressed as mean ± standard error.   
RESULTS AND DISCUSSION 
Phytochemical analysis  
The results of preliminary phytochemical screening of the leaf extract of Physalis minima from different solvent system 
revealed the presence of flavonoids, alkaloids, tannins, saponins, steroids, cardiac glycosides, reducing sugars and 
terpenoids (Table 1).  Members of the Solanaceae like Solanum nigrum, Physalis peruviana, Capsicum fruitescence etc. 
have proven anti-cancer as well as anti-inflammatory activity.  They possess medicinal properties like antimicrobial, anti-
oxidant, cytotoxic properties, antiulcerogenic, and hepatoprotective activity. Solanum nigrum is a potential herbal 
alternative as anti-cancer agent and one of the active principles reported to be responsible for this action is Diosgenin [22, 
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23]. Plants are storehouse of pre-synthesized molecules that act as lead structures, which can be optimized for new drug 
development.  In practice, a large number of cancer chemotherapeutic agents that are currently available in the market 
can be traced back to their plant source [24].   
Determination of Total phenolics and flavonoids 
Evaluation of total phenolic contents revealed that methanolic leaf extract showed 78.3 mg/g of phenolic compounds. The 
phenolic concentration of the extract was expressed as milligram of gallic acid equivalents per gram of extract.  Likewise, 
methanolic leaf extract showed 61.3 mg/g of flavonoid.  The flavonoid content was expressed as mg quercetin equivalent 
per gram of extract. The results of the present work strongly suggest that phenolic compounds are important components 
of this plant and some of their pharmacological effects could be attributed to the presence of these valuable constituents. 
Thus, the anticancer activity of the extract could be predicted from its total phenolic content. The interests in phenolic 
compounds, particularly flavonoids and tannins have considerably increased in recent years because of their broad 
spectrum of chemical and diverse biological properties which include the antioxidant effects [25]. It is suggested that 
polyphenolic compounds have inhibitory effects on mutagenesis and carcinogenesis in humans, when up to 1.0 g daily 
ingested from a diet rich in fruits and vegetables [26].  
Anticancer activity 
Viability and characterization of cell lines 
Percentage cell viability of cell lines was carried out by using Trypan blue dye exclusion technique. It was found 
that the % viability of HeLa cell line & Hep
2 
cell line are 80% & 71.8% respectively, which are most suitable to perform 
cytoxicity studies. 
Sulphorhodamine B (SRB) assay  
Results are tabulated in Table 2. The percentage growth inhibition was found to be increasing with increasing 
concentration of test compounds against both the cell lines (HeLa and Hep
2
). The methanolic extract showed the 
strongest growth inhibitory effect on both HeLa and Hep
2 
cell lines (68 and 58% respectively) whereas in comparison ethyl 
acetate and acetone extract demonstrated moderate cytotoxic effect with % inhibition of 51 & 47 for HeLa and 58 & 50 for 
Hep
2 
cell lines respectively (Table 2). In contrast hexane and aqueous extract did not show cytotoxic effect at any 
concentration.  The result indicates that the methanolic leaf extract of Physalis minima has potential activity on both HeLa 
and Hep
2 
cell lines. The chloroform extract of P. minima is reported to possess cytotoxic activities on NCI-H23 (human 
lung adenocarcinoma) cell line at dose- and timedependent manners. They exert programmed cell death in NCI-H23 cells 
with typical DNA ftagmentation, which is a biochemical Hallmark of apoptosis [27].  
MTT assay 
In the present investigation, the leaf extract of Physalis minima showed significant effects on the tumor inhibition 
activities against cell lines of HeLa and Hep
2
 in MTT assay.  It was found that the percent growth inhibition increasing with 
increasing concentration on both the cell lines. The methanolic extract showed the strongest growth inhibitory effect on 
both HeLa and Hep
2 
cell lines( 85 and 73%) whereas, in comparison ethyl acetate and acetone extract demonstrated 
moderate cytotoxic effect with % inhibition of 58 & 65 for  HeLa and 51 & 61 for Hep
2 
cell lines respectively (Table 3). In 
contrast hexane and aqueous extract did not show cytotoxic effect at any concentration.  The result indicates that the 
methanolic leaf extract of Physalis minima has potential activity on both HeLa and Hep
2 
cell lines. The chloroform extract 
showed anticancer activity against human T-47D breast carcinoma cells. The cytotoxic action of chloroform extract is 
reported to be due to induced apoptotic cell death via, p53, caspase-3 and c-myc-dependent pathways [28]. It has been 
reported that, chloroform extract exhibited anticancer activity in human ovarian Caov-3 carcinoma. Cytotoxicity of the 
extract was measured using the methylene blue assay [29].  
Identification of the compounds 
In this study, compounds showing anticancer activity have been isolated and partially purified from the 
methanolic leaf extract of Physalis minima. The isolated compounds were identified as flavonoids.  Plants have been a 
prime source of highly effective conventional drugs for the treatment of many forms of cancer. Physalis minima  has been 
reported to contain withanone, withaferin A, withanolide A, stigmasterol, sitosterol have been reported from leaves, root 
and stem while withanolide A, withanone, withaferin (fruits and flowers), dihydroxyphysalin B2-4 and physalins A. B and X. 
It also contain physalindicanols, withaphysalin E, withaphysalin C, withaphysalin D, withaphysalin A, physalinicanol A 
withametelins, physalin, withanolide, withangulatins, vitasteroids, phygrine, withaphysalin A, B, C, D, E and physalin A, C, 
B, D, I, L, withanone, withaferin A and withanolide A. The plant contains seven withanolides like physalindicanols A and B, 
withamin and withphysalin E and other includes physalin B, D, C and 3-0- glucosides of kaemferol and quercetin. Physalin 
A, B, C and flavanoids, physalin H, isophysalin B, and 5β, 6β-epoxyphysalin B. Two new physalins have been isolated 
from the whole plant of P. minima. It is also reported to contain withaminimin, phygrine (alkaloid), physalin L, a 13,l4-seco-
16,24 cyclosteroid, other compound physalin B, epoxyphysalin B and physalin D, flavonoid, viz. 5-methoxy-6, 7-
methylenedioxyflavone and 5,6, 7-trimethoxyflavone and bitter principles[30].    
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CONCLUSIONS 
In conclusion, the results obtained in the in vitro models such as SRB assay and MTT assay clearly suggests that, the 
methanolic leaf extract of Physalis minima showed strong cytotoxic activity. The results of the present work strongly 
suggest that phenolic compounds are important components of this plant and some of their pharmacological effects could 
be attributed to the presence of these valuable constituents. Thus, the anticancer activity of the extract could be predicted 
from its total phenolic content. The study showed that the extracts can be used as easily accessible source of natural 
anticancer agents and as a possible food supplement.  
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